Chemotherapy, anti-cancer drugs that stop the growth of tumor cells, encompasses a wide variety of different agents.  Some ...

Oral cancer is one of the most common head and neck cancers worldwide, with hundreds of thousands of new cases diagnosed every year. Despite advances in surgery, radiotherapy, and chemotherapy, ...

"ESMO 2025: J&J eyes Rybrevant indication expansion to HNSCC on Phase II victory" was originally created and published by ...

A research team at the Seville Biomedical Institute (IBis) has identified a new molecular mechanism that explains the high ...

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune ...

Merus N.V., an oncology-focused company, announced the publication of research on petosemtamab, a bispecific antibody targeting EGFR and LGR5, in the journal "Cancers." The study highlights the ...

A research team led by Prof. Ben Ko Chi-bun, Associate Professor of the PolyU Department of Applied Biology and Chemical Technology, has discovered the critical mechanism of action of tetrandrine, a ...